Current guidelines in heart failure management

Ethnicity and Disease

Volumn 12, Issue 1, 2002, Pages

  Durand, Jean Bernard ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; AMLODIPINE; ANGIOTENSIN; ANGIOTENSIN I; ANGIOTENSIN RECEPTOR ANTAGONIST; ARGIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENDOTHELIN; FIBRINOLYTIC AGENT; KIDNEY RENIN; LISINOPRIL; LOSARTAN; METOPROLOL; MILRINONE; NATRIURETIC FACTOR; NEUROHORMONE; NORADRENALIN; SPIRONOLACTONE; VALSARTAN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EDEMA; FATIGUE; FEMALE; HEART ARRHYTHMIA; HEART CONTRACTION; HEART FAILURE; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; LUNG CONGESTION; MALE; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION; SUDDEN DEATH; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; CARDIOTONIC AGENTS; COMBINED MODALITY THERAPY; DIET; EXERCISE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SMOKING CESSATION; SURVIVAL RATE;

EID: 0036244281     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. 2001 heart and stroke statistical update
2. Consensus recommendations for the management of chronic heart failure
3. The effect of digoxin on mortality and morbidity in patients with heart failure
4. The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure
5. Effects of enalapril on mortality in severe congestive heart failure
6. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
7. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
8. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomized trial-the Losartan Heart Failure Survival Study ELITE II
9. Comparison of candesartan, enalapril, and their combination in congestive heart failure: Randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study
10. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
11. Beta-adrenergic receptor blockade in chronic heart failure
12. A randomized trial of beta-blockade in heart failure
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial
14. Three-year follow-up of patients randomized in the metoprolol in dilated cardiomyopathy trial
15. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
16. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
17. Effect of carvedilol on survival in severe chronic heart failure
18. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF)
19. Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization, and costs
20. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure
21. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: The CAPRICORN randomized trial
22. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
23. The sixth report of the Joint Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
24. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death
25. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial
26. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
27. Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials